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Abstract
Iatrogenic perimembranous ventricular septal defect is a rare complication after surgical
replacement of the aortic valve, and so transcatheter closure of such a defect is not a routine
procedure.  We report the successful closure of an iatrogenic perimembranous ventricular
septal defect which occurred after the replacement of the aortic valve and ascending aorta.
(Cardiol J 2008; 15: 189–191)
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Introduction
Iatrogenic perimembranous ventricular septal
defect is a rare complication after surgical replace-
ment of the aortic valve. Small defects are usually
hemodynamically insignificant and do not need to
be closed. However, some of the small ventricular
septal defects occurring after such surgery may
gradually enlarge, and subsequent intervention may
be indicated. Since 2002, when Hijazi et al. [1] pu-
blished their initial experience of percutaneous clo-
sure of congenital perimembranous ventricular sep-
tal defect with an Amplatzer membranous ventri-
cular septal defect  occluder, this procedure has
been considered an alternative to surgical closure
in several centres [2–4]. However, transcatheter
closure of iatrogenic perimembranous ventricular
septal defect after aortic valve replacement was first
described by Holzer et al. [5] in 2004 and is not
routine procedure.
We report the successful closure of an iatroge-
nic perimembranous ventricular septal defect
(PMVSD) which occurred after previous replace-
ment of the aortic valve, and subsequent replacement
of the ascending aorta and valve with composite graft.
Case report
A 70-year-old male with a history of aortic va-
lve replacement with St Jude prosthesis performed
three years previously was admitted with type-A
acute ascending aortic dissection. Urgent replace-
ment of the aortic valve and dissected ascending
aorta was performed. In view of the age of the
patient and the heavily damaged tissues in the aor-
tic ring, a modified composite graft made of a Da-
cron tube with incorporated Hancock II valve bio-
prosthesis was used, similar to the technique descri-
bed by Urbanski [6]. The post-operative course was
complicated by a complete heart block, which needed
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implantation of a pacemaker, and prolonged mecha-
nical ventilation due to chronic obstructive pulmo-
nary disease. Transthoracic and subsequent trans-
oesophageal echocardiography revealed a restricti-
ve 6 mm PMVSD. Because of the lack of symptoms
(New York Heart Association functional class II) and
the shunt estimated as hemodynamically insignifi-
cant, the patient was managed conservatively and
sent home. However, six months later the patient
showed deterioration of exercise capacity to New
York Heart Association functional class III/IV. Echo-
cardiography revealed that the ventricular septal
defect had increased in size from 6 mm to 10 mm.
Because of his general condition and previous sur-
gical history, percutaneous closure of the perimem-
branous ventricular septal defect was recommended
to avoid the risk of yet another surgical intervention.
The procedure was performed with a standard
technique using fluoroscopic and transoesophage-
al echocardiographic guidance [1].
Right femoral vein and right femoral artery
approach was used. The aortic bioprosthesis was
crossed using a 6 F, 3.5 cm Judkins right coronary
catheter over a 0.035” Terumo glide wire (Teru-
mo). A 6 F pigtail catheter was advanced over a wire
to the left ventricle. Left ventriculography demon-
strated a 10 mm perimembranous ventricular sep-
tal defect (Fig. 1). Consequently, the pigtail cathe-
ter was exchanged for a 6 F, 3.5 cm Judkins right
coronary catheter. The tip of catheter was manipu-
lated to the PMVSD, and the glide wire was advan-
ced to the right ventricle and the main pulmonary
artery. The Judkins catheter was advanced to the
main pulmonary artery and the glide wire was
exchanged for a 0.035”, 300 cm long Noodle wire
(AGA Medical). The wire was snared from the main
pulmonary artery using a 25 mm Gooseneck snare
(Microvena) and exteriorized out the right femoral
vein. Over the wire from the venous side, an 8 F
Torqueview delivery sheath (AGA Medical) was
advanced. During attempts to pass the delivery
sheath through the ventricular septal defect, the
ventricular pacing lead was dislodged, so a tempo-
rary pacing lead was placed in the right ventricle.
The ventricular septal defect was closed using the
technique described in detail by Hijazi et al. [1].
A 12 mm Amplatzer perimembranous ventricular
septal defect occluder was used. Angiography after
implantation of the device revealed a trivial leak
through the mesh of the device (Fig. 2). The pro-
cedure was otherwise uncomplicated and at the end
a new permanent pacing electrode was implanted.
Echocardiography a day after the procedure showed
complete closure of the ventricular septal defect.
Follow-up assessments six months and one year
after the procedure confirmed complete closure of
the ventricular septal defect, no aortic bioprosthe-
sis dysfunction and improvement of symptoms to
New York Heart Association functional class II.
Figure 1. Cineangiographic image in the long-axial oblique
view demonstrating the ventricular septal defect (blue ar-
row) and position of aortic bioprosthesis (white arrow).
Figure 2. Cineangiographic image in the long-axial obli-
que view after implantation of a device in the ventricu-
lar septal defect demonstrating a trivial leak through
the centre of the device (white arrow), position of aortic
bioprosthesis (white star) and displacement of ventri-
cular pacing electrode (blue arrow).
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Discussion
Percutaneous closure of ventricular septal de-
fects is an alternative to the surgical treatment in se-
lected cases. Ventricular septal defects are a rare com-
plication after cardiac surgery but they may occur
more often in patients who have undergone repeat
cardiac surgery in the left ventricular outflow tract.
In such patients, further repeat surgery may carry an
increased operative risk. Therefore, percutaneous
treatment with a device is an attractive therapeutic
option. Results of transcatheter closure of iatrogenic
ventricular septal defect, even in patients with me-
chanical aortic valve prosthesis, have been published
in the past few years and are very encouraging. Hol-
zer et al. [5] first described two patients with iatroge-
nic perimembranous ventricular septal defect after
aortic valve replacement, who were treated by trans-
catheter interventional device closure. Our patient
underwent an operation in which a dissection of the
ascending aorta and previously implanted mechani-
cal aortic valve prosthesis were removed and repla-
ced with a composite graft using a biological valve
sewn into a Dacron tube using Urbanski’s method.
The prosthetic valve in this type of operation is sewn
into the aortic graft, a few millimetres above the le-
vel of the native aortic orifice (Fig. 3). Urbanski’s me-
thod allows the use of a prosthetic valve of at least one
size bigger than conventional conduits and carries the
advantage of easily obtaining a tight, elastic and hemo-
static composite graft connection to the left ventricle.
In our case, the distance between the proximal aortic
valvular edge and the upper border of the ventricular
septal defect allowed percutaneous closure of the ia-
trogenic defect using a device. Special care must be
taken when crossing the aortic bioprosthesis to avoid
damage to the prosthesis leaflet.
Iatrogenic ventricular septal defect is a rare but
potentially serious complication of aortic valve re-
placement and may be difficult to treat. Interven-
tional closure of a hemodynamically significant pe-
rimembranous ventricular septal defect with an
Amplatzer PMVSD occluder (AGA Medical) is po-
ssible in patients in whom a ventricular septal de-
fect is likely to occur after previous replacement of
the ascending aorta and valve.
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Figure 3. Schematic demonstration of the position of
ventricular septal defect (blue arrow) and bioprosthesis
(black arrow). Note the intermittent line shows previous
prosthetic valve position.
